Is Apolipoprotein E ε2 Associated with Delayed Onset of Non-Lesional Temporal Lobe Epilepsy?

Acta Clin Croat. 2017 Mar;56(1):10-14. doi: 10.20471/acc.2017.56.01.02.

Abstract

The aim of the study was to evaluate the possible association between Apo E polymorphisms and age at seizure onset in patients with non-lesional temporal lobe epilepsy. Eighty patients with non-lesional temporal lobe epilepsy with or without bilateral tonic-clonic propagation were analyzed. Age at seizure onset was defined as age at the first unequivocal seizure (excluding febrile convulsions). ApoE alleles were determined by a procedure where genome DNA was amplified by chain reaction along with polymerase, using the LightCycler kit (Roche) for ApoE mutations on codons 112 and 158. There was a statistically significant difference between the groups of patients with ApoE ε2/3 and ε3/4 genotypes (p=0.03), but not between patients with ApoE, ε2/3 and ε3/3, and those with ApoE ε3/4 and ε3/3. In conclusion, the results of our study suggested positive association of a specific ApoE genotype and onset of non-lesional temporal lobe epilepsy.

Keywords: Apolipoprotein E2; Polymorphism, genetic; Epilepsy, temporal lobe; Age at Onset.

MeSH terms

  • Adult
  • Age of Onset
  • Alleles
  • Apolipoprotein E2 / genetics*
  • Apolipoprotein E3 / genetics*
  • Apolipoprotein E4 / genetics*
  • Apolipoproteins E / genetics
  • Case-Control Studies
  • Epilepsy, Temporal Lobe / genetics*
  • Female
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Mutation
  • Polymorphism, Genetic

Substances

  • Apolipoprotein E2
  • Apolipoprotein E3
  • Apolipoprotein E4
  • Apolipoproteins E